In vivo, human parathyroid hormone fragment (hPTH 1-34) transiently stimulates immediate early response gene expression, but not proliferation, in trabecular bone cells of young rats.

Intermittent PTH increases trabecular bone mass in vivo by stimulating osteoblast differentiation to increase bone formation. The molecular events that mediate the anabolic effect of PTH on osteoblasts have not been characterized. We investigated if PTH regulated mRNA expression of proto-oncogenes, c-fos, c-jun, and c-myc, early response genes that have been shown to be involved in the regulation of both cell proliferation and differentiation. As PTH also regulates the early expression of the cytokine, interleukin-6 (IL-6), in bone cells in vitro, we also investigated if this occurred in vivo, in concert with the other early response genes. Northern blot hybridization was used to analyze mRNA expression in the metaphysis of the distal femur of young rats. To determine the proliferative state in these femurs, mRNA expression of the cell proliferation marker histone, H4, was assessed. Subcutaneous administration of a single injection of human PTH (1-34) at 8 micrograms/100 g, a dose known to increase bone forming surfaces, induced rapid and transient expression of c-fos, c-jun, c-myc, and IL-6 mRNA. A second novel transcript for IL-6 was detected, but its significance remains unknown. Induction of all these messages was evident by 1 h; the levels of mRNA returned to baseline after 3-6 h. Concurrently, PTH had a small inhibitory effect on the expression of histone H4 mRNA. We conclude that, in vivo, PTH upregulates cell differentiation in trabecular bone by transient stimulation of the early response genes and IL-6, while downregulating cell proliferation.

[1]  G S Stein,et al.  Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. , 1993, Endocrine reviews.

[2]  G. Ciliberto,et al.  Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion. , 1994, The EMBO journal.

[3]  M. Hattori,et al.  Structure of the rat interleukin 6 gene and its expression in macrophage-derived cells. , 1989, The Journal of biological chemistry.

[4]  E. Hu,et al.  Targeted disruption of the c‐fos gene demonstrates c‐fos‐dependent and ‐independent pathways for gene expression stimulated by growth factors or oncogenes. , 1994, The EMBO journal.

[5]  S. Bloch,et al.  Signal transduction pathways mediating parathyroid hormone regulation of osteoblastic gene expression , 1994, Journal of cellular biochemistry.

[6]  J. A. Parsons CHAPTER 5 – Parathyroid Physiology and the Skeleton , 1976 .

[7]  P. Angel,et al.  Phenotypic alterations in fos-transgenic mice correlate with changes in Fos/Jun-dependent collagenase type I expression. Regulation of mouse metalloproteinases by carcinogens, tumor promoters, cAMP, and Fos oncoprotein. , 1994, The Journal of biological chemistry.

[8]  J. Potts,et al.  Short-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients. , 1981, The Journal of clinical investigation.

[9]  E. Ogata,et al.  Transcriptional activation of c‐fos and c‐jun protooncogenes by serum growth factors in osteoblast‐like MC3T3‐E1 cells , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  Y. Tan,et al.  Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1. , 1994, The Journal of biological chemistry.

[11]  J. Clohisy,et al.  Parathyroid hormone induces c-fos and c-jun messenger RNA in rat osteoblastic cells. , 1992, Molecular endocrinology.

[12]  K. Wright,et al.  Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Hock,et al.  Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats. , 1988, Endocrinology.

[14]  B. Spiegelman,et al.  Pleiotropic effects of a null mutation in the c-fos proto-oncogene , 1992, Cell.

[15]  J. Hock,et al.  Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  L. Melton,et al.  The prevention and treatment of osteoporosis. , 1992, The New England journal of medicine.

[17]  C. Kleeman,et al.  Interleukin-6 attenuates agonist-mediated calcium mobilization in murine osteoblastic cells. , 1994, The Journal of clinical investigation.

[18]  R. Boyce,et al.  Resorption is not essential for the stimulation of bone growth by hPTH‐(1‐34) in rats in vivo , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  G. Segre,et al.  Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: in situ localization of its receptor and c-fos messenger ribonucleic acids. , 1994, Endocrinology.

[20]  T. Martin,et al.  Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34 on bone in rats. , 1989, Endocrinology.

[21]  M. Greenberg,et al.  The regulation and function of c-fos and other immediate early genes in the nervous system , 1990, Neuron.

[22]  P. Gruss,et al.  Proto-oncogene c-fos expression in growth regions of fetal bone and mesodermal web tissue , 1987, Nature.

[23]  J Reeve,et al.  Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. , 1980, British medical journal.

[24]  J. Clohisy,et al.  Parathyroid hormone induces transcription of collagenase in rat osteoblastic cells by a mechanism using cyclic adenosine 3',5'-monophosphate and requiring protein synthesis. , 1992, Molecular endocrinology.

[25]  V. Papadopoulos,et al.  Sertoli cell differentiation on basement membrane is mediated by the c-fos protooncogene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Cole The myc oncogene: its role in transformation and differentiation. , 1986, Annual review of genetics.

[27]  M. Karin,et al.  The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. , 1991, Biochimica et biophysica acta.

[28]  F. Hughes,et al.  Interleukin-6 inhibits bone formation in vitro. , 1993, Bone and mineral.

[29]  R. Lindsay,et al.  Anabolic actions of parathyroid hormone on bone. , 1993, Endocrine reviews.

[30]  M. Greenberg,et al.  Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells. , 1985, The Journal of biological chemistry.

[31]  J. McCubrey,et al.  Phorbol esters support the proliferation of a hematopoietic cell line by upregulating c-jun expression. , 1994, Oncogene.

[32]  G. Stein,et al.  Aberrant gene expression in cultured mammalian bone cells demonstrates an osteoblast defect in osteopetrosis , 1994, Journal of cellular biochemistry.

[33]  O. Tørring,et al.  Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum. , 1993, Calcified tissue international.

[34]  R. Turner,et al.  The effect of long-term ovarian hormone deficiency on transforming growth factor-beta and bone matrix protein mRNA expression in rat femora. , 1994, Biochemical and biophysical research communications.

[35]  M. Davie,et al.  Prostaglandin E2 stimulates the production of interleukin-6 by neonatal mouse parietal bones. , 1994, Bone and mineral.

[36]  T. Jones Interleukin‐6 an endocrine cytokine , 1994, Clinical endocrinology.

[37]  L. Quarles,et al.  Molecular to pharmacologic control of osteoblast proliferation and differentiation , 1994, Journal of cellular biochemistry.

[38]  G. Bourne,et al.  The biochemistry and physiology of bone , 1956 .

[39]  B. Spiegelman,et al.  Protooncogene c-fos as a transcription factor. , 1990, Advances in cancer research.

[40]  G. Stein,et al.  Histone gene transcription: A model for responsiveness to an integrated series of regulatory signals mediating cell cycle control and proliferation/differentiation interrelationships , 1994, Journal of cellular biochemistry.

[41]  G. Strassmann,et al.  Interleukin 6 production in fetal rat long bone cultures is correlated with PGE2 release and does not correlate with the extent of bone resorption. , 1994, Cytokine.

[42]  Erwin F. Wagner,et al.  Deregulated c-fos expression interferes with normal bone development in transgenic mice , 1987, Nature.

[43]  H. Donahue,et al.  Regulation of cytokine expression in osteoblasts by parathyroid hormone: Rapid stimulation of interleukin‐6 and leukemia inhibitory factor mRNA , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[44]  G. Passeri,et al.  Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal. , 1993, Endocrinology.

[45]  G. Stein,et al.  Specific interactions of histone H1 and a 45 kilodalton nuclear protein with a putative matrix attachment site in the distal promoter region of a cell cycle‐regulated human histone gene , 1989, Journal of cellular physiology.

[46]  J. Hoyland,et al.  Upregulation of c‐Fos protooncogene expression in pagetic osteoclasts , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.